Annual Accounts Payable
$2.38 M
+$1.45 M+154.51%
31 December 2023
Summary:
Context Therapeutics annual accounts payable is currently $2.38 million, with the most recent change of +$1.45 million (+154.51%) on 31 December 2023. During the last 3 years, it has fallen by -$324.90 thousand (-12.00%). CNTX annual accounts payable is now -12.00% below its all-time high of $2.71 million, reached on 31 December 2020.CNTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$1.03 M
+$417.20 K+68.23%
01 September 2024
Summary:
Context Therapeutics quarterly accounts payable is currently $1.03 million, with the most recent change of +$417.20 thousand (+68.23%) on 01 September 2024. Over the past year, it has dropped by -$799.10 thousand (-43.72%). CNTX quarterly accounts payable is now -66.64% below its all-time high of $3.08 million, reached on 30 September 2021.CNTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTX Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +154.5% | -43.7% |
| 3 y3 years | -12.0% | -66.6% |
| 5 y5 years | - | - |
CNTX Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -12.0% | +154.5% | -66.6% | +126.2% |
| 5 y | 5 years | -12.0% | +154.5% | -66.6% | +126.2% |
| alltime | all time | -12.0% | +154.5% | -66.6% | +126.2% |
Context Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.03 M(+68.2%) |
| June 2024 | - | $611.50 K(-70.1%) |
| Mar 2024 | - | $2.05 M(-14.2%) |
| Dec 2023 | $2.38 M(+154.5%) | $2.38 M(+30.4%) |
| Sept 2023 | - | $1.83 M(+53.5%) |
| June 2023 | - | $1.19 M(-1.6%) |
| Mar 2023 | - | $1.21 M(+29.3%) |
| Dec 2022 | $936.30 K | $936.30 K(-37.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $1.50 M(+58.1%) |
| June 2022 | - | $945.50 K(+107.9%) |
| Mar 2022 | - | $454.80 K(-75.1%) |
| Dec 2021 | $1.83 M(-32.6%) | $1.83 M(-40.8%) |
| Sept 2021 | - | $3.08 M(+79.4%) |
| June 2021 | - | $1.72 M(-9.0%) |
| Mar 2021 | - | $1.89 M(-30.3%) |
| Dec 2020 | $2.71 M(+30.9%) | $2.71 M |
| Dec 2019 | $2.07 M | - |
FAQ
- What is Context Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Context Therapeutics?
- What is Context Therapeutics annual accounts payable year-on-year change?
- What is Context Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Context Therapeutics?
- What is Context Therapeutics quarterly accounts payable year-on-year change?
What is Context Therapeutics annual accounts payable?
The current annual accounts payable of CNTX is $2.38 M
What is the all time high annual accounts payable for Context Therapeutics?
Context Therapeutics all-time high annual accounts payable is $2.71 M
What is Context Therapeutics annual accounts payable year-on-year change?
Over the past year, CNTX annual accounts payable has changed by +$1.45 M (+154.51%)
What is Context Therapeutics quarterly accounts payable?
The current quarterly accounts payable of CNTX is $1.03 M
What is the all time high quarterly accounts payable for Context Therapeutics?
Context Therapeutics all-time high quarterly accounts payable is $3.08 M
What is Context Therapeutics quarterly accounts payable year-on-year change?
Over the past year, CNTX quarterly accounts payable has changed by -$799.10 K (-43.72%)